Evidence map›Paper›PMID 42694954›Full record

ArticleFrontiers in medicine2026

Washed microbiota transplantation is associated with

Yi-Shu Wang, Yao-Fei Wei, Wei-Ran Chen, Zhi-Ning Ye, Hui-Min Zhou, Hao-Jie Zhong, Xing-Xiang He

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yi-Shu Wang *Department of Gastroenterology/Microbiota Medicine, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Yao-Fei Wei *Department of Gastroenterology/Microbiota Medicine, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Wei-Ran Chen *Department of Gastroenterology/Microbiota Medicine, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Zhi-Ning YeDepartment of Gastroenterology/Microbiota Medicine, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Hui-Min ZhouDepartment of Gastroenterology/Microbiota Medicine, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Hao-Jie ZhongDepartment of Gastroenterology/Microbiota Medicine, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Xing-Xiang HeDepartment of Gastroenterology/Microbiota Medicine, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong Province, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antibiotic resistance remains a major challenge in the management of Methods: This retrospective observational study included two independent cohorts from January 2020 to January 2025. The WMT outcome cohort comprised patients with baseline Results: The WMT cohort included 42 patients [mean age, 56.60 ± 14.65 years; 30 men (71.43%)]. During a median follow-up of 196.5 days (IQR, 44.5-595.0 days), 23 patients achieved post-WMT Conclusion: In this retrospective uncontrolled study, WMT exposure was associated with subsequent

Indexed as

fecal microbiota transplantationHelicobacter infectionsHelicobacter pyloriinnate lymphoid cellspeptic ulcer

Identifiers

PMID42694954
PMCPMC13540426

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.